Edison, NJ, United States of America

Dominick F Gratale


Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 73(Granted Patents)


Company Filing History:


Years Active: 1999-2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Dominick F. Gratale: Innovator in Pharmaceutical Development

Introduction

Dominick F. Gratale, based in Edison, New Jersey, is an accomplished inventor with a notable record of three patents to his name. His contributions to the field of pharmacology, particularly in the realm of diabetes and metabolic disorders, highlight his expertise and commitment to advancing medical science.

Latest Patents

Among Dominick's latest patents are innovations that include "Arylthiazolidinedione derivatives." These substituted 5-aryl-2,4-thiazolidinediones have been identified as potent agonists of PPAR, making them useful in the treatment, control, or prevention of diabetes, hyperglycemia, hyperlipidemia (including hypercholesterolemia and hypertriglyceridemia), atherosclerosis, obesity, vascular restenosis, and other PPAR-mediated diseases. Another significant patent is the invention of a "Process for the stereoselective synthesis of certain 16.beta.-substituted 4-aza-5.alpha.-androstan-3-ones," which details a novel process involving the stereoselective synthesis of useful intermediates.

Career Highlights

Dominick currently works at Merck & Company, Inc., a leading global healthcare company dedicated to improving health and well-being. His innovative patents reflect both his scientific knowledge and his ability to translate complex biochemical concepts into practical applications that have meaningful impacts on health management.

Collaborations

Throughout his career, Dominick has teamed up with notable colleagues including Soumya P. Sahoo and Richard L. Tolman. These collaborations foster a creative and innovative environment that has led to significant advancements in pharmaceutical research and development.

Conclusion

Dominick F. Gratale stands as a prominent figure in the field of patent innovation, particularly in pharmaceuticals. His work demonstrates a commitment to enhancing healthcare solutions, and his ongoing contributions are likely to influence the future of medical treatment and preventive care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…